Pulmonary Hypertension Observational Study
Recruiting now
Conditions studied: Pulmonary Hypertension
In brief
The purpose of this study is to establish the large PH cohort and biological database in China, aiming for precision medicine to optimize diagnosis and treatment choices.
Key facts
- Study ID
- NCT05958901
- Run by
- The First Affiliated Hospital of Guangzhou Medical University
- People needed
- 10000
- Starts
- 2023-07-12
- Expected to finish
- 2027-12-30
- Last updated by the study team
- 2023-07-25
Who can join
Age: 20 and older, up to 70. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- PH group: When the mean pulmonary artery pressure is greater than 25mmHg at rest or greater than 30mmHg during exercise.
- Signed informed consent obtained prior to participations with the ability to comply with protocol and be available for study visits over 5 years.
You may not qualify if…
- Acute exacerbation in the past 3 months Having other respiratory diseases with massive lung tissue destruction such as severe bronchiectasis and tuberculosis, etc.
- Serious uncontrolled diseases thoracic or abdominal surgery in the last 3 months.
- Eye surgery in the last three months.
- Retinal detachment myocardial infarction in the last 3 months.
- Admission to hospital for any cardiac condition in the last month.
- Heart rate over 120 beats per minute.
- Antibacterial chemotherapy for tuberculosis pregnant or breast feeding.
Where it is running
- The First Affiliated Hospital of Guangzhou Medical University — Guangzhou, Guangdong, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.